Research Highlights Importance of Patient-Centered Sarcoma Surveillance
A 2022 study explored how sarcoma patients feel about long-term surveillance imaging after treatment, highlighting the emotional, financial, and practical…
Study Finds Tumor Size and Surgical Margins are Key Drivers of Synovial Sarcoma Outcomes
A new multi-center retrospective study from three major U.S. sarcoma centers has analyzed outcomes in patients with localized synovial sarcoma,…
North America Synovial Sarcoma Treatment Market Expected to Grow Through 2033
New industry analyses project continued growth in the North America synovial sarcoma treatment market, with a predicted compound annual growth…
Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis
Synovial sarcoma is a rare and aggressive soft tissue cancer that most often develops near the joints of the arms…
Synovial Sarcoma Foundation Wins First Place at the 16th Annual SPAGN Conference
We are incredibly honored to share that the Synovial Sarcoma Foundation received First Place in the Advocacy in Action Award…
Synovial Sarcoma Foundation Welcomes Lucia and Roberto Belluco to the Board of Directors
[Philadelphia, PA] The Synovial Sarcoma Foundation (SSF) is honored to welcome Lucia Manzinello Belluco and Roberto Belluco to its Board…
Synovial Sarcoma Research and Rare Cancer Drug Development: Challenges and Progress
Developing treatments for rare cancers like synovial sarcoma remains one of the biggest challenges in modern medicine—but recent progress shows…
New Research Identifies 4 Subtypes of Synovial Sarcoma, Opening Doors for Personalized Treatment
Synovial sarcoma is a rare and aggressive soft tissue cancer, but new research is helping us better understand how it…
What a Breakthrough in Ewing Sarcoma Means for Synovial Sarcoma
A new Phase 1/2 trial in Ewing sarcoma, just profiled in Clinical Trial Vanguard and published in Nature Medicine, delivered…